関与物質
| 役割 | 名称 | HCID | 仕込み量 |
|---|
| 反応物 | 1-Heptyne | HCID 12350 | — |
| 反応物 | Leukotriene B4 | HCID 5280492 | — |
| 反応物 | (-)-Glycidol | HCID 6973630 | — |
| 反応物 | L-Ascorbic Acid | HCID 54670067 | — |
| 溶媒 | Diethyl Ether | HCID 3283 | — |
| 生成物 | a-[(tetrahydro-2H-pyran-2-yl)oxy]dec-4-yn-2(R)-ol | HCID 14464847 | — |
反応手順
The starting material for the process of this invention, compound 2, can be prepared as described in Nicolaou, K. C. et al., "A General and Stereocontrolled Total Synthesis of Leukotriene B4 and Analogues," J. Am. Chem. Soc., 106, 3548 (1984) or Hanson, R. M. and Sharpless, K. B., J. Org. Chem., 51 1922 (1986). Briefly, optically active (S)-glycidol THP ether is prepared from ascorbic acid as disclosed in Takano, S., Numata, H., Ogasawara, K., Heterocycles, 19, 237 (1982) and Baldwin, J. J., Raab, A. W., Mensler, K., Arison, B. H., McClure, D. E., J. Org. Chem., 43, 4876 (1978). The ether is reacted (-78°-25° C.) with two equivalents of the anion of 1-heptyne (1.0 equiv. of n-BuLi, 1.0 equiv. of TMEDA and THF, -78° C.) to afford a-[(tetrahydro-2H-pyran-2-yl)oxy]dec-4-yn-2(R)-ol which is then silylated (t-BuPh2SiCl, imidazole, DMF) to, compound 2.
情報源と証拠
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 特許番号 | US04873024 |
|---|
| 出典データセット | uspto-grants-1989_10 |
|---|
| ORD ID | ord-491ea872368f4a6580fbc8c0e583bfc3 |
|---|
| 出典メモ | uspto-grants-1989_10 |
|---|